Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Circ Heart Fail. 2015 May 18;8(4):702–708. doi: 10.1161/CIRCHEARTFAILURE.115.002097

Table 1.

Baseline characteristics of Chronic Renal Insufficiency Cohort participants without chronic heart failure by quartile of Initial Kansas City Cardiomyopathy Questionnaire (KCCQ) Score*

Quartile I (N=779) II (N=813) III (N=766) IV (N=735) P Value
KCCQ Score ≤74.5 74.6–91.7 91.8–99.0 >99
Age (years) 60 (10) 60 (10) 60 (12) 58 (11) 0.001
Female 55% 47% 42% 35% <0.001
Race <0.001
Non-Hispanic White 32% 40% 53% 56%
Non-Hispanic Black 51% 45% 32% 29%
Hispanic 13% 12% 10% 10%
Other 4% 3% 5% 6%
Diabetes mellitus 61% 52% 39% 33% <0.001
Current Smoker 18% 13% 10% 8% <0.001
Current Alcohol Use 42% 56% 67% 70% <0.001
Cardiovascular Disease** 41% 32% 22% 16% <0.001
Body Mass Index (kg/m2) 35.4 (8.9) 32.2 (7.4) 30.2 (6.3) 29.2 (5.6) <0.001
Systolic Blood Pressure (mmHg) 130 (23) 129 (22) 125 (20) 122 (19) <0.001
Diastolic Blood Pressure (mmHg) 70 (14) 70 (14) 70 (12) 71 (11) 0.60
eGFR (mL/min/1.73m2) 39.2 (16.0) 40.9 (16.4) 44.3(16.3) 50.1 (16.8) <0.001
24-hour Urine Protein (g/24hrs.) 1.2 (2.2) 1.0 (2.1) 0.7 (1.5) 0.6(1.4) <0.001
Hemoglobin (g/dL) 12.3 (1.8) 12.6 (1.8) 13.1 (1.7) 13.5 (1.6) <0.001
Low-density lipoprotein (mg/dL) 100 (37) 100 (35) 100 (34) 102 (32) 0.36
High-density lipoprotein (mg/dL) 47 (15) 49 (16) 50 (16) 50 (16) <0.001
NT-proBNP (pg/mL) 163 (71, 415) 152 (69, 375) 119 (58, 273) 79 (36, 179) <0.001
Troponin T (pg/mL) 13 (6, 24) 12 (6, 23) 10 (5, 19) 8 (4, 16) <0.001
*

Note: Mean (Standard Deviation) reported for continuous variables and percentage for categorical variables. P values are obtained using ANOVA or Kruskal-Wallis tests for continuous variables and Chi-square tests for categorical variables.

**

Cardiovascular disease was defined as a self-reported history of coronary artery disease, myocardial infarction or stroke.

Reported as Median (Interquartile Range)

Abbreviations: estimated glomerular filtration rate (eGFR); N-terminal pro b-type natriuretic peptide (NT-proBNP)